Product Information
CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0169 per EA under NDC 00093342210. Its NADAC has been published 262 times since Aug 18, 2021.
FDA first approved this application on May 3, 1989. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093342210
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071611FDA Approved
5/3/1989
TE Code
AB
On Market Since
7/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 262 times since Aug 18, 2021, and over the history we have for it it has declined 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0169 per EA |
|---|---|
| All-time high | $0.0267 (Mar 16, 2022) |
| All-time low | $0.0144 (Nov 20, 2024) |
| 52-week high | $0.0192 |
| 52-week low | $0.0169 |
| Median price | $0.0203 |
| Average price | $0.0205 |
| Largest weekly change | +32.5% (Jun 19, 2024) |
| Weeks tracked | 262 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0169 per EA (NDC 00093342210), effective Aug 19, 2026.
How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has declined 30.9%. It has been tracked across 262 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?
Since Aug 18, 2021, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0144 (Nov 20, 2024) to a high of $0.0267 (Mar 16, 2022), with a median of $0.0203 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 10 MG TABLET?
CYCLOBENZAPRINE 10 MG TABLET (NDC 00093342210) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.